Fourth Order Derivative Spectrophotometric Determination of Benzyl Alcohol in Piroxicam Injections

Piroxicam is a drug with analgesic and anti‐inflammatory properties. It is present in numerous pharmaceutical preparations. Injectable forms usually contain benzyl alcohol as an excipient, which is used as a blocking anesthetic (4%) and an antiseptic (4–10%). In this work, spectrophotometric methodology was used in order to determine benzyl alcohol in piroxicam injectable formulations by applying the fourth derivative method adopting the zero‐crossing technique. The results obtained show that the method has significant advantages over other reported methods and is appropriate for routine pharmaceutical analysis. The method showed excellent linearity in the range of 2–100 μg mL^?1 with limit of detection (S/N = 3) 0.07 μg mL^?1 (6.47 × 10^?7 M). The proposed method could be applied successfully for the determination of benzyl alcohol in injectable formulations with average % recovery of 100 ± 0.61.     

First and second order derivative spectrophotometric determination of benzyl alcohol and diclofenac in pharmaceutical forms

Diclofenac sodium is a drug with analgesic, antipyretic and anti-inflammatory properties. It is present in numerous pharmaceutical preparations. In injectable forms, it is usually accompanied by benzyl alcohol as an excipient, which is used as a blocking anesthetic (4%) and an antiseptic (4-10%). In this work spectrophotometric methodology was used in order to determine diclofenac and benzyl alcohol in injectable formulations by applying, on the one hand, the first-derivative method of crossing zero for diclofenac sodium and on the other, second derivative for benzyl alcohol. The results obtained show that this method has a significant advantage over other techniques and it is appropriate for routine pharmaceutical analysis.     

Application of Solid-Phase Extraction Coupled with Dispersive Liquid–Liquid Microextraction for the Determination of Benzaldehyde in Injectable Formulation Solutions

Solid-phase extraction followed by dispersive liquid–liquid microextraction (SPE-DLLME) technique has been developed as a new analytical approach for extracting, cleaning up and preconcentrating benzaldehyde, a toxic oxidation product of the widely used preservative and co-solvent benzyl alcohol, in injectable formulation solutions. SPE of benzaldehyde from samples was carried out using C₁₈ sorbent. After the elution of benzaldehyde from the sorbent by using acetonitrile, DLLME technique was performed on the obtained solution. Benzaldehyde was preconcentrated by using DLLME technique. Thus, 1.5 mL acetonitrile extract (disperser solvent) and 55.0 µL 1,2-dichloroethane (extraction solvent) were added to 5 mL ultra pure water and a DLLME technique was applied. Several variables that govern the proposed technique were studied and optimized. Under optimum conditions, the method detection limit (LOD) of benzaldehyde calculated as three times the signal-to-noise ratio (S/N) was 0.08 µg L^?1. The relative standard deviation (RSD) for four replicates was 5.8 %. The calibration graph was linear within the concentration range of 0.5–500 µg L^?1 for benzaldehyde. The proposed method has been successfully applied to the analysis of the benzaldehyde in injectable formulation solutions (diclofenac, vitamin B-complex and voltaren) and the relative recoveries were between 88 and 92 % and show that matrix has a negligible effect on the performance of the proposed method.     

人工神经网络紫外光度法同时测定甲基苯甲醛的三种同分异构体及其与偏最小二乘法的比较

同分异构体的同时测定一直是分析化学领域的热点和难点问题,本文将化学计量学中的多元校正方法,如偏最小二乘法和人工神经网络法与紫外分光光度法相结合,同时测定了紫外吸收光谱严重重叠的甲基苯甲醛的三种同分异构体混合体系中各组分的含量。确定了测定的最佳波长范围为230～304 nm;测得48个混合标样的吸光度值用于建立模型,其中,邻、间、对甲基苯甲醛的浓度范围分别为6.0～15.0、7.0～16.0和8.0～19.0 μg·mL-1。7个模拟样品作为监测集用于检验所建立模型的预测性能。本文还讨论了三种组分浓度比例对所建立模型预测性能的影响并确定了可以准确测定的浓度比例范围。所建立的方法用于模拟样品的测定,其回收率在84.00%与109.60%之间。与偏最小二乘法的测定结果比较,经成对t检验表明,两种方法对邻、间甲基苯甲醛测定结果无显著性差异;而对甲基苯甲醛的测定,人工神经网络法的测定结果优于偏最小二乘法。     

A new diclofenac membrane sensor based on its ion associate with crystal violet. Application to diclofenac determination in urine and pharmaceuticals

A novel diclofenac ion-selective electrode has been prepared and used in pharmaceutical analysis. The ion-associate of diclofenac with basic dye (crystal violet) was used as the membrane carrier. Among the four different solvent mediators tested, dibutylphthalate (DBP) exhibited proper behavior including the Nernstian slope of the calibration curve, fast response time and good reproducibility of the emf values. The electrode exhibits a Nernstian slope of 59 ± 1 mV decade^?1 for diclofenac in the concentration range 5.0 × 10^?5-5.0 × 10^?2 M with the limit of detection of 2.5 × 10^?5 M. The electrode displays good sensitivity with the respect to a number of common inorganic and organic species. It can be used in a pH range of 6–11. The membrane sensor was successfully applied to the determination of diclofenac in capsules and for its recovery from urine samples.     

Application of Multivariate Calibration Methods for the Simultaneous Multiwavelength Spectrophotometric Determination of Fe(II), Cu(II), Zn(II), and Mn(II) in Mixtures

Abstract

A sensitive method for the simultaneous spectrophotometric determination of Fe(II), Cu(II), Zn(II), and Mn(II) in mixtures has been developed with the aid of multivariate calibration methods, such as classical least squares (CLS), principal component regression (PCR) and partial least squares (PLS). The method is based on the spectral differences of the analytes in their complexation reaction with 4‐(2‐pyridylazo)‐resorcinol (PAR) and the use of full spectra with wavelengths in the range of 300–600 nm. It was found that both the spectral positive and negative bands obtained against the PAR blank, are proportional to the concentration for each metal complex. The obtained linear calibration concentration ranges are 0.025–0.6, 0.05–0.8, 0.025–0.8, and 0.05–0.8 µg ml^?1 for Fe(II), Cu(II), Zn(II), and Mn(II), respectively, and the LODs for the four metal ions were found to be approximately 1–3×10^?2 µg ml^?1. The proposed method was applied to a verification set of synthetic mixtures of these four metal ions, with models built in three different wavelength ranges, i.e., 300–450, 450–600, and 300–600 nm, corresponding to the positive, negative bands and their combinations, respectively. It was shown that the PLS model for the 300–600 nm range gave the best results (RPE_T=6.9% and average recovery ～100%; cf. PCR: RPE_T=9.5% and average Recovery ～110%). This method was also successfully applied for the determination of the four metal ions in pharmaceutical preparations, chicken feedstuff, and water samples.     

Simultaneous spectrophotometric determination of minoxidil and tretinoin by the H-point standard addition method and partial least squares

A simple, sensitive and selective spectrophotometric method for simultaneous determination of tretinoin and minoxidil using partial least square (PLS) calibration and H-point standard addition method (HPSAM) is described. The results of the H-point standard addition method show that minoxidil and tretinoin can be determined simultaneously with the concentration ratio of tretinoin to minoxidil varying from 2: 1 to 1: 33 in mixed samples. A partial least squares multivariate calibration method for the analysis of binary mixtures of tretinoin and minoxidil was also developed. The total relative standard error for applying the PLS method to eleven synthetic samples in the concentration range of 0–10 μg mL⁻¹ tretinoin and 0–32 μg mL⁻¹ minoxidil was 2.59 %. Both proposed methods (PLS and HPSAM) were also successfully applied in the determination of tretinoin and minoxidil in several synthetic pharmaceutical solutions.     

Simultaneous Spectrophotometric Determination of Uranium and Thorium Using Arsenazo III by H‐Point Standard Addition Method and Partial Least Squares Regression

Simultaneous determination of uranium and thorium using arsenazo III as a chromogenic reagent at pH 1.70 by H‐point standard addition method (HPSAM) and partial least squares (PLS) calibration is described. Under optimum conditions, the simultaneous determinations of uranium and thorium by HPSAM were performed. The absorbencies at one pair of wavelengths, 649 and 669 nm, were monitored with the addition of standard solutions of uranium. The results of applying the HPSAM showed that uranium and thorium can be determined simultaneously with weight concentration ratios of uranium to thorium varying from 20:1 to 1:15 in the mixed sample. By multivariate calibration methods such as PLS, it is possible to obtain a model adjusted to the concentration values of the mixtures used in the calibration range. In this study, the calibration model is based on absorption spectra in the 600–750 nm range for 25 different mixtures of uranium and thorium. Calibration matrices contained 0.10–21.00 and 0.25–18.5 μg mL^?1 of uranium and thorium, respectively. The RMSEP for uranium and thorium were 0.7400 and 0.7276, respectively. Both proposed methods (HPSAM and PLS) were also successfully applied to the determination of uranium and thorium in several synthetic and real matrix samples.     

Resolution of mixtures of three nonsteroidal anti-inflammatory drugs by fluorescence using partial least squares multivariate calibration with previous wavelength selection by Kohonen artificial neural networks

A spectrofluorometric method for the quantitative determination of flufenamic, mefenamic and meclofenamic acids in mixtures has been developed by recording emission fluorescence spectra between 370 and 550 nm with an excitation wavelength of 352 nm. The excitation–emission spectra of these compounds are deeply overlapped which does not allow their direct determination without previous separation. The proposed method applies partial least squares (PLS) multivariate calibration to the resolution of this mixture using a set of wavelengths previously selected by Kohonen artificial neural networks (K-ANN). The linear calibration graphs used to construct the calibration matrix were selected in the ranges from 0.25 to 1.00 μg ml⁻¹ for flufenamic and meclofenamic acids, and from 1.00 to 4.00 μg ml⁻¹ for mefenamic acid. A cross-validation procedure was used to select the number of factors. The selected calibration model has been applied to the determination of these compounds in synthetic mixtures and pharmaceutical formulations.     

Simultaneous Determination of Bifonazole and Benzyl Alcohol in Pharmaceutical Formulations by Reverse-Phase HPLC

A simple, precise and sensitive reverse-phase high performance liquid chromatographic (RP-HPLC) method has been developed for the quantitation of bifonazole, an imidazole antifungal, simultaneously with benzyl alcohol, used as preservative, in pharmaceutical formulations. Method employed Zorbax Eclipse XDB-C18 (250×4.6 mm i.d., 5 m) column, methanol - ammonium acetate (pH 2; 65 mM) (65:35, v/v, pH^* 3.6) as mobile phase with flow rate of 1 mL min^–1 and variable UV detection at 220 and 252 nm. The proposed method was validated by testing its linearity, selectivity, recovery, repeatability, LOD/LOQ values and it was successfully employed for the determination of bifonazole and benzyl alcohol in pharmaceutical cream-based formulations.     

Spectrophotometric determination of hydrocortisone, nystatin and oxytetracycline in synthetic and pharmaceutical preparations based on various univariate and multivariate methods

Two spectrophotometric methods are described and applied to resolve ternary mixtures of the corticosteroid hydrocortisone (HYD) and the antibiotics nystatin (NYS) and oxytetracycline (OXY). The simultaneous determination of these three compounds was firstly accomplished by a derivative method using the “ratio spectrum-zero crossing derivative” and then by multivariate methods partial least squares (PLS)-1, -2 and principal component regression (PCR). Multivariate calibration methods provide, specially PLS-2 in this case, a clear example of the high resolving powder of these techniques. The two described procedures do not require any separation step. Repeatability and reproducibility studies were achieved over two series of 10 standards for each compound showing no significant differences at 95% confidence level in the four spectrophotometric methods. A comparison of the derivative and multivariate calibration results obtained in pharmaceutical formulations was performed resulting in agreement of the values obtained and the results was confirm by a high-pressure liquid chromatography (HPLC) method.     

New Spectrophotometric Method for Azithromycin Determination

Abstract

Azithromycin (AZT), an antibiotic belonging to the family of macrolides, can be analyzed by a new spectrophotometric method based on the formation of an ion pair between this drug and an inorganic complex of (Mo(V)–thiocyanate) followed by its extraction with dichloroethane. This ion‐association complex shows an orange color and exhibits a maximum absorbance at 469 nm. The experimental conditions of the reaction were studied and optimized. The calibration graph was linear (r=0.9996) over the range 10^?6 M–10^?5 M of AZT. This simple and validated method has been successfully applied to the determination of azithromycin in pharmaceutical formulations with a mean relative standard deviation of 1.07% and mean recovery of 99.66%. The common excipients present in azithromycin formulations did not interfere in its determination. This new spectophotometric method has been applied successfully to illustrate the dissolution profiles of original tablets and generic compounds; hence, it could be employed in routine quality control of azithromycin in pharmaceutical dosage forms.     

Stopped-flow fluorimetric determination of amoxycillin and clavulanic acid by partial least-squares multivariate calibration

Mixtures of amoxycillin and clavulanic acid were determined by using kinetic data in combination with partial least-squares multivariate calibration. The reaction of oxidation of these compounds with cerium(IV) in sulfuric acid medium has been monitored fluorimetrically. To follow the kinetics of the reaction, the stopped-flow mixing technique was used. Partial least-squares calibration of the kinetic data allowed the resolution of the analytes investigated in the concentration ranges between 0 and 4 mugml(-1). The method was applied satisfactorily to several pharmaceutical formulations, including Clavucid, Augmentine, Pangamox, Eupeclanic and Clamoxyl. The results obtained were validated by using an HPLC method. The percentages of recovery range from 91 to 105% for amoxycillin and from 78 to 117% for clavulanic acid, respectively.     

Development and Validation of a Liquid Chromatographic Method for the Determination of Leflunomide: Application to in vitro Drug Metal Interactions

Leflunomide is a leading drug for the treatment of rheumatoid arthritis. The principle aim of this study was to develop and validate an RP‐HPLC method for the determination of leflunomide in bulk and pharmaceutical dosage form using diclofenac sodium as an internal standard. For this purpose, chromatography was accomplished on a Purospher Start, C₁₈ (5 (m, 12.5 cm×0.46 cm) column at ambient temperature. Methanol:water (80:20, V/V) solvent system was selected as mobile phase, the pH of which was adjusted to 3.4 by ortho‐phosphoric acid and delivered at a flow rate of 1.2 mL·min⁻¹. Seperation of leflunomide and diclofenac sodium was carried out on a Purospher Start, C₁₈ equipped with a UV‐visible detector at 248 nm. The suitability of the method for the quantitative determination of the drugs is proven by validation in accordance with the requirements laid down by the International Conference on Harmonization (ICH) guidelines. The method was accurate (99.55%–100.03%), specific, linear (R²>0.999) and precise (intra‐day precision 0.023%–0.93% and inter‐day precision 0.26%–0.944%) in the range of 0.5–20 (g·mL⁻¹. The minimum limit of detection and quantification in pharmaceutical formulation were 0.05 and 0.15 (g·mL⁻¹, respectively. Thus the proposed method is simple, accurate, reproducible and suitable for the routine analysis of leflunomide in pharmaceutical formulations and was applied to study in vitro drug‐metal interactions.     

New validated liquid chromatographic and chemometrics-assisted UV spectroscopic methods for the determination of two multicomponent cough mixtures in syrup

Multivariate spectrophotometric calibration and liquid chromatographic (LC) methods were applied to the determination of 2 multicomponent mixtures containing diprophylline, guaiphenesin, methylparaben, and propylparaben (Mixture 1), or clobutinol, orciprenaline, saccharin sodium, and sodium benzoate (Mixture 2). For the multivariate spectrophotometric calibration methods, principal component regression (PCR) and partial least-squares regression (PLS-1), a calibration set of the mixtures consisting of the components of each mixture was prepared in 0.1 M HCl. Analytical figures of merit such as sensitivity, selectivity, limit of quantitation, and limit of detection were determined for both PLS-1 and PCR. The LC separation was achieved on a reversed-phase C18 analytical column by using isocratic elution with 20 mM potassium dihydrogen phosphate, pH 3.3-acetonitrile (55 + 45, v/v) as the mobile phase and UV detection at 260 and 220 nm for Mixture 1 and Mixture 2, respectively. The proposed methods were validated and successfully applied to the analysis of pharmaceutical formulations and laboratory-prepared mixtures containing the 2 multicomponent combinations.     

Solvent extraction-spectrophotometric determination of trace amounts of fluoxetine in pharmaceutical formulations

A simple, reproducible, and sensitive extraction-spectrophotometric method for the determination of fluoxetine (FL) in pharmaceutical formulations is reported. The FLH⁺ cation, which is formed in an acidic solution, can form an ion-pair with Orange II, (OR II), an anionic dye. The FLH⁺-OR II⁻ ion pair was quantitatively extracted into dichloromethane solvent and its absorption was measured at 482 nm. The calibration graph is linear over the FL concentration range of 0.2–9.0 μg/mL and the regression coefficient is 0.9995. The relative standard deviation (RSD) of ten replicate determinations of 5.0 and 1.4 μg/mL of FL are 0.022 and 0.038, respectively, and the limit of detection (LOD) of the method is 0.17 μg/mL. The method was successfully applied to the determination of an FL amount in pharmaceutical formulations (10.0-and 20.0-mg capsules). The text was submitted by the authors in English.     

Carbon Nanotube Based Sensor for Simultaneous Determination of Acetaminophen and Ascorbic Acid Exploiting Multiple Response Optimization and Measures in the Presence of Surfactant

A simple procedure for the simultaneous determination of acetaminophen (AC) and ascorbic acid (AA) by differential pulse voltammetry (DPV) using a carbon nanotube paste electrode exploiting measures in cetylpyridinium bromide (CPB) medium is described. Under the best instrumental parameters of DPV, optimized by means of factorial design, the calibration plots in the range 100.0–700.0 µmol L^?1 (r=0.993) and 39.4–146.3 µmol L^?1 (r=0.995) with limits of detection of 7.1 and 2.1 µmol L^?1, were achieved for AA and AC, respectively. The developed method was successfully applied for the AC and AA determination in pharmaceutical formulations, whose accuracy was attested by comparison with HPLC method.     

Determination of the antibacterial enrofloxacin by differential-pulse adsorptive stripping voltammetry

Two new methods for the determination of enrofloxacin in commercial formulations and canine urine samples, based on adsorptive stripping voltammetry (AdSV), are proposed. One of the proposed method uses univariate calibration to analyse enrofloxacin in commercial formulations and the other applies principal component regression (PCR) to the voltammetric measurements to determine enrofloxacin in the presence of its metabolite ciprofloxacin. The linear concentration ranges of application were 4-25 and 18-55 ng ml⁻¹ by using an accumulation potential of −0.3 V and a 180 or 60 s accumulation time, respectively for the univariate method. The first concentration range was used for the multivariate method. Both methods were successfully applied to the analysis of commercial formulations and spiked canine urine samples, respectively.     

Simultaneous voltammetric determination of levodopa, carbidopa and benserazide in pharmaceuticals using multivariate calibration

An analytical methodology based on differential pulse voltammetry (DPV) on a glassy carbon electrode and the partial least-squares (PLS-1) algorithm for the simultaneous determination of levodopa, carbidopa and benserazide in pharmaceutical formulations was developed and validated. Some sources of bi-linearity deviation for electrochemical data are discussed and analyzed. The multivariate model was developed as a ternary calibration model and it was built and validated with an independent set of drug mixtures in presence of excipients, according with manufacturer specifications. The proposed method was applied to both the assay and the uniformity content of two commercial formulations containing mixtures of levodopa-carbidopa (10:1) and levodopa-benserazide (4:1). The results were satisfactory and statistically comparable to those obtained by applying the reference Pharmacopoeia method based on high performance liquid chromatography. In conclusion, the methodology proposed based on DPV data processed with the PLS-1 algorithm was able to quantify simultaneously levodopa, carbidopa and benserazide in its pharmaceuticals formulations using a ternary calibration model for these drugs in presence of excipients. Furthermore, the model appears to be successful even in the presence of slight potential shifts in the processed data, which have been taken into account by the flexible chemometric PLS-1 approach.     

Kinetic spectrophotometric determination of hyoscine butylbromide in pure form and in pharmaceutical formulations

A simple and sensitive kinetic method was described for the determination of hyoscine butylbromide in pharmaceutical preparations. The method is based upon a kinetic investigation of the oxidation reaction of the drug with alkaline potassium permanganate at room temperature for a fixed time of 15 min. The absorbance of the colored manganate ion was measured at 610 nm. The absorbance–concentration plot was rectilinear over the range of 1.0–10 μg mL^?1 (r = 0.9999) and detection limit of 0.092 μg mL^?1. The concentration of hyoscine butylbromide was calculated using the corresponding calibration equation for the fixed-time method. The determination of hyoscine butylbromide by the fixed-concentration and rate constant methods is also feasible with the calibration equations obtained but the fixed-time method has been found to be more applicable. The different experimental parameters affecting the development and stability of the colors were carefully studied and optimized. The proposed method was applied to the determination of hyoscine butylbromide in pharmaceutical formulations. The results obtained were in good agreement with those obtained using the official British Pharmacopeial method (2004).